Chardan Capital Reiterates “Buy” Rating for 22nd Century Group (XXII)

[ad_1]

Phenopen Evaluation CBD

Having said that, investments in the hemp industry, (see beneath), will reduce the business’s money balances modestly. Under the operating line, the company … Study Much more

The post Chardan Capital Reiterates “Buy” Rating for 22nd Century Group (XXII) appeared initial on Dagga Magazine.

Phenopen.com

[ad_2]

Latest posts